Department of Emergency Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea.
Department of Emergency Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Crit Care. 2019 Jun 18;23(1):224. doi: 10.1186/s13054-019-2510-x.
We hypothesized that the absence of P25 and the N20-P25 amplitude in somatosensory evoked potentials (SSEPs) have higher sensitivity than the absence of N20 for poor neurological outcomes, and we evaluated the ability of SSEPs to predict long-term outcomes using pattern and amplitude analyses.
Using prospectively collected therapeutic hypothermia registry data, we evaluated whether cortical SSEPs contained a negative or positive short-latency wave (N20 or P25). The N20-P25 amplitude was defined as the largest difference in amplitude between the N20 and P25 peaks. A good or poor outcome was defined as a Glasgow-Pittsburgh Cerebral Performance Category (CPC) score of 1-2 or 3-5, respectively, 6 months after cardiac arrest.
A total of 192 SSEP recordings were included. In all patients with a good outcome (n = 51), both N20 and P25 were present. Compared to the absence of N20, the absence of N20-P25 component improved the sensitivity for predicting a poor outcome from 30.5% (95% confidence interval [CI], 23.0-38.8%) to 71.6% (95% CI, 63.4-78.9%), while maintaining a specificity of 100% (93.0-100.0%). Using an amplitude < 0.64 μV, i.e., the lowest N20-P25 amplitude in the good outcome group, as the threshold, the sensitivity for predicting a poor neurological outcome was 74.5% (95% CI, 66.5-81.4%). Using the highest N20-P25 amplitude in the CPC 4 group (2.31 μV) as the threshold for predicting a good outcome, the sensitivity and specificity were 52.9% (95% CI, 38.5-67.1%) and 96.5% (95% CI, 91.9-98.8%), respectively. The predictive performance of the N20-P25 amplitude was good, with an area under the receiver operating characteristic curve (AUC) of 0.94 (95% CI, 0.90-0.97). The absence of N20 was statistically inferior regarding outcome prediction (p < 0.05), and amplitude analysis yielded significantly higher AUC values than did the pattern analysis (p < 0.05).
The simple pattern analysis of whether the N20-P25 component was present had a sensitivity comparable to that of the N20-P25 amplitude for predicting a poor outcome. Amplitude analysis was also capable of predicting a good outcome.
我们假设体感诱发电位(SSEP)中 P25 和 N20-P25 振幅缺失的敏感性高于 N20 缺失,用于预测不良神经结局,并通过模式和振幅分析评估 SSEP 预测长期结局的能力。
我们使用前瞻性收集的治疗性低温登记数据,评估皮质 SSEP 是否包含负或正短潜伏期波(N20 或 P25)。N20-P25 振幅定义为 N20 和 P25 峰值之间的最大振幅差异。良好或不良结局定义为心脏骤停后 6 个月格拉斯哥-匹兹堡脑功能预后评分(CPC)为 1-2 或 3-5。
共纳入 192 例 SSEP 记录。在所有预后良好的患者(n=51)中,N20 和 P25 均存在。与 N20 缺失相比,N20-P25 成分缺失提高了预测不良结局的敏感性,从 30.5%(95%置信区间[CI],23.0-38.8%)到 71.6%(95%CI,63.4-78.9%),同时保持 100%(93.0-100.0%)的特异性。使用振幅<0.64μV(即预后良好组中 N20-P25 振幅的最低值)作为阈值,预测不良神经结局的敏感性为 74.5%(95%CI,66.5-81.4%)。使用 CPC 4 组中 N20-P25 振幅最高值(2.31μV)作为预测良好结局的阈值,敏感性和特异性分别为 52.9%(95%CI,38.5-67.1%)和 96.5%(95%CI,91.9-98.8%)。N20-P25 振幅的预测性能良好,受试者工作特征曲线下面积(AUC)为 0.94(95%CI,0.90-0.97)。与结果预测相比,N20 的缺失具有统计学意义(p<0.05),且振幅分析的 AUC 值显著高于模式分析(p<0.05)。
N20-P25 成分缺失的简单模式分析对预测不良结局的敏感性与 N20-P25 振幅相当。振幅分析也能够预测良好的结局。